Documents

Y0001555

Ciclesonide impurity B

European Pharmacopoeia (EP) Reference Standard

Synonym(s):
Desisobutyryl-ciclesonide, (2′R)-2′-Cyclohexyl-11b,21-dihydroxy-16bH-1,3dioxolo4′,5′:16,17pregna-1,4-diene-3,20-dione
Empirical Formula (Hill Notation):
C28H38O6
CAS Number:
Molecular Weight:
470.60
NACRES:
NA.24
Pricing and availability is not currently available.

biological source

synthetic

grade

pharmaceutical primary standard

Agency/Method

EP

form

powder

CofA

certificate is enclosed in each package

packaging

pkg of 10 mg

mfr. no.

EDQM

storage condition

protect from light

solubility

water: <0.1 g/L

Featured Industry

Pharmaceutical (small molecule)

format

neat

shipped in

ambient

General description

Ciclesonide impurity B is an impurity of ciclesonide, a new-generation, non-halogenated glucocorticoid.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the
issuing Pharmacopoeia.

Application

Ciclesonide impurity B is used as a pharmaceutical primary standard to quantify the analyte in pharmaceutical formulations by liquid chromatography (LC) technique.

Packaging

Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Caution

Other Notes

Sales restrictions may apply.
Certificate of Analysis
Certificate of Origin
New Drugs for Asthma, Allergy and COPD, 42, 42-54 (2001)
Ciclesonide
European Pharmacopoeia Commission and European Directorate for the Quality of Medicines & Healthcare
European pharmacopoeia, 43, 2206-2207 (2017)
Pharmacokinetics of [14 C] ciclesonide after oral and intravenous administration to healthy subjects
Nave R, et al.
Clinical Pharmacokinetics, 43, 479-486 (2004)
Rethinking Cleaning Validation for API Manufacturing
Zhang C, et al.
Pharmaceutical Technology, 42, 42-54 (2018)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.